Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Negri
Brandon Andrew Negri, Lafayette, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110239370 | SYSTEMS FOR RELIEVING PRESSURE SORES AND METHODS THEREFOR - A pressure sore relief system includes a plurality of sensors in communication with a surface, whereby each sensor operates independently of one another for detecting a pressure level at a particular region of the surface and generating a feedback signal that corresponds to the detected pressure level, and a system controller adapted to receive the feedback signals from the sensors and generate a plurality of output signals in response to each of the feedback signals. The pressure sore relief system includes a plurality of actuators in communication with the surface and being adapted to receive the output signals from the system controller, whereby each output signal generated by the system controller is associated with one of the actuators. The actuators are adapted to selectively vibrate for minimizing the likelihood of a patient developing pressure sores. The pressure sore relief system may be positioned over a mattress or a chair. | 10-06-2011 |
Daria Negri, Nesher IL
| Patent application number | Description | Published |
|---|---|---|
| 20110069312 | METROLOGY SYSTEMS AND METHODS - Various metrology systems and methods are provided. | 03-24-2011 |
Ettore Negri, Garbagnate IT
| Patent application number | Description | Published |
|---|---|---|
| 20090192184 | Crystalline Polymorphs of Topotecan Hydrochloride and Methods for the Preparation Thereof - The invention relates to two novel crystalline form of Topotecan hydrochloride (Ia) | 07-30-2009 |
Ettore Negri, Rodano IT
| Patent application number | Description | Published |
|---|---|---|
| 20100179180 | CRYSTALLINE IRINOTECAN HYDROCHLORIDE AND METHODS FOR ITS PREPARATION - Disclosed is a crystalline form of irinotecan hydrochloride (I) and processes for the preparation thereof from crude irinotecan hydrochloride or another polymorphic form of irinotecan. Said crystalline form is particularly suitable for industrial use, because it is easily filtered and possesses characteristics of high stability and purity. | 07-15-2010 |
Joanna Teresa Negri, Mystic, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20100035891 | Pharmaceutically Active Compounds - Compounds of the formula (I): | 02-11-2010 |
Joseph Negri, Boston, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20100172893 | Use of Reversine and Analogs For Treatment of Cancer - Herein is provided methods and compositions for treating cancer. In one embodiment, a method is provided for treating a patient suffering from cancer, the method comprising administering to the patient an effective amount of reversine, reversine analog or reversine containing agent. In another embodiment, compositions comprising reversine are provided. Such compositions may further comprise additional active agents and other additives. The compositions and methods provided herein are useful, for example, in the area of medicine. | 07-08-2010 |
Joseph Negri, E. Falmouth, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20100286090 | Treatment of Multiple Myeloma - Methods for treating multiple myeloma comprising administering a therapeutically effective amount of dasatinib to a patient in need of treatment thereof. Dasatinib can be administered alone or in combination with a second anti-neoplastic agent such as dexamethasone or bortezomib. The patient may be refractory to prior treatment with an anti-neoplastic agent other than dasatinib. | 11-11-2010 |
Ronald E. Negri, Minnetonka, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20100237240 | SAMPLE HOLDER APPARATUS TO REDUCE ENERGY OF ELECTRONS IN AN ANALYZER SYSTEM AND METHOD - A sample holder apparatus and method for reducing the energy of charged particles entering an annular-acceptance analyzer includes use of an electrically isolated sample support member having a sample receiving surface configured to receive a sample and electrically connect the sample to the sample support member (e.g., wherein the sample support member is configured for application of a retarding bias potential). A grounded sample aperture member defining an aperture relative to the sample support member but electrically isolated therefrom is provided such that the aperture is proximate the sample receiving surface to expose at least a portion of a surface of a sample received thereon to be analyzed (e.g., wherein applying a retarding bias potential to the sample support member produces an electrical retarding field about the aperture that reduces the energy of emitted particles from a sample before they enter an annular-acceptance analyzer). | 09-23-2010 |
Umberto Negri, Bologna IT
| Patent application number | Description | Published |
|---|---|---|
| 20090137789 | Oligonucleotide Probes - Fluorescent oligonucleotide probe having a general formula (I), wherein Onu represents an oligonucleotide residue, Thio | 05-28-2009 |